China Biologic Products Inc. (NASDAQ:CBPO)

Wednesday, March 2, 2016 | Web News
BEIJING, March 1, 2016 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the...
Friday, February 26, 2016 | Web News
Fourth Quarter 2015 Financial Results Total sales in the fourth quarter of 2015 increased by 22.6% in RMB terms, or 17.8% in...
Wednesday, November 4, 2015 | Web News
Third Quarter 2015 Financial Results Total sales in the third quarter of 2015 increased by 14.4% to $78.8 million from $68.9...

At least one FIE exists in the corporate structure

China Biologic Products, Inc., through its indirect majority-owned subsidiary, Shandong Taibang, is currently the only plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province with a population of 93 million. The company is engaged primarily in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China.

Web site: http://www.ctbb.com.cn/

Last updated March 17, 2008